Aspirin 300mg

DRUG4 trials

Sponsors

University College, London, NHS Lothian, Instituto Mexicano del Seguro Social, Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions

Anticoagulant-induced BleedingBreast CancerCancerColorectal CancerEczemaGastro-oesophageal CancerMigrainePatent Foramen Ovale

Phase 2

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

CompletedNCT05515120

Instituto Mexicano del Seguro SocialAnticoagulant-induced Bleeding, Pulmonary Embolism, Venous Thromboembolism +1

Start: 2021-01-03End: 2022-07-01Updated: 2022-08-25

Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

CompletedNCT05546320

Chinese Academy of Medical Sciences, Fuwai HospitalMigraine, Patent Foramen Ovale

Start: 2022-10-15End: 2025-03-26Updated: 2026-04-22

Phase 3

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Active, not recruitingNCT02804815

University College, LondonBreast Cancer, Cancer, Colorectal Cancer +2

Start: 2015-10-31End: 2026-10-31Target: 11000Updated: 2025-06-10

Unknown Phase

PGE2/IL-22 Pathway in Various Forms of Eczema

CompletedNCT04133506

NHS LothianEczema

Start: 2021-11-04End: 2025-11-30Updated: 2026-02-10

Related Papers

Study design and rationale of COMPETE: Comparison of the effect of medication therapy in alleviating migraine with patent foramen ovale.

2023-12-161 citations